603567.SH
珍宝岛
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 5.32
−5.67%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.1x
Market Cap
CNY 5.00B
MomentumView details →
1D Return
−5.67%
YTD Return
−38.19%
RSI (14)
42.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.1x
Market Cap
CNY 5.00B
RSI (14)
42.3
MomentumView details →
1D Return
−5.67%
YTD Return
−38.19%
Similar companies
Latest newsMore news →
Zhenbaodao's independent directors issued opinions on the Shanghai Stock Exchange's 2025 annual report inquiry letter, disclosing that the controlling shareholder had non-operationally occupied company funds of 233 million yuan (already disclosed) and an additional 66.0236 million yuan in 2022 through Heilongjiang Jinjiu Pharmaceutical Co., Ltd., all of which have been fully repaid.8d agoZhenbaodao announced its first-half 2026 results, reporting a net loss of 271 million yuan, compared with a loss of 78.29 million yuan in the same period of 2025.8d agoZhenbaodao received a letter of inquiry from the Shanghai Stock Exchange regarding its annual report and has responded, with multiple issues still under investigation.58d ago